|
|
||||||||
Journal of Lipid Research, Vol 37, 2065-2073, Copyright © 1996 by Lipid Research, Inc.
N Sakai, S Santamarina-Fojo, S Yamashita, Y Matsuzawa and HB Brewer Jr
Cholesteryl ester transfer protein (CETP) deficiency is the most common
cause of hyperalphalipoproteinemia in Japan. However, the genetic basis of
this disorder has not been fully characterized. We have studied a 49-
year-old Japanese male presenting with total cholesterol, HDL- cholesterol,
and apolipoprotein A-I levels of 300, 236, and 233 mg/dl, respectively, and
total absence of CETP activity and mass in plasma. Sequence analysis of the
patient's CETP gene revealed that the splice donor consensus GT was
substituted by GG in intron 10 (intron 10 splice defect) and by AT in
intron 14 (intron 14 splice defect). Restriction digestion of PCR-amplified
DNA using NdeI and MaeIII established that the patient was a compound
heterozygote for both gene defects. Sequencing of cDNA amplified by RT-PCR
from the patient's monocyte- derived macrophage RNA demonstrated abnormal
splicing with deletion of exon 10 as well as alternative splicing at a
native AG site located 31 nucleotides 5' of the normal splice acceptor in
intron 13. Thus, the intron 10 splice defect results in exon 10 skipping
and the insertion of a 31 bp fragment between exon 13 and exon 14, which
contains an in frame stop codon. The presence of abnormally spliced mRNA
was further confirmed by amplification of patient cDNA using CETP specific
primers. Abnormal splicing of exon 14 as a result of the intron 14 splice
defect was not detected, indicating potential unstable CETP mRNA derived
from that mutation. These findings demonstrate that a novel splice site
mutation in intron 10 of the CETP gene results in the skipping of exon 10,
as well as disruption of downstream splicing at intron 13 identifying a
novel mechanism leading to CETP deficiency.
ARTICLES
Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection
Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1666, USA.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A J Brea-Fernandez, E Pomares, M J Brion, G Marfany, M J Blanco, M Sanchez-Salorio, R Gonzalez-Duarte, and A Carracedo Novel splice donor site mutation in MERTK gene associated with retinitis pigmentosa Br. J. Ophthalmol., October 1, 2008; 92(10): 1419 - 1423. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Lira, A. K. Loomis, S. A. Paciga, D. B. Lloyd, and J. F. Thompson Expression of CETP and of splice variants induces the same level of ER stress despite secretion efficiency differences J. Lipid Res., September 1, 2008; 49(9): 1955 - 1962. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Boekholdt and J. F. Thompson Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease J. Lipid Res., July 1, 2003; 44(6): 1080 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nagano, S. Yamashita, K.-i. Hirano, M. Ito, T. Maruyama, M. Ishihara, Y. Sagehashi, T. Oka, T. Kujiraoka, H. Hattori, et al. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader (R) assay J. Lipid Res., July 1, 2002; 43(7): 1011 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nagano, S. Yamashita, K.-i. Hirano, T. Kujiraoka, M. Ito, Y. Sagehashi, H. Hattori, N. Nakajima, T. Maruyama, N. Sakai, et al. Point Mutation (-69 G{->}A) in the Promoter Region of Cholesteryl Ester Transfer Protein Gene in Japanese Hyperalphalipoproteinemic Subjects Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 985 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Rittershaus, D. P. Miller, L. J. Thomas, M. D. Picard, C. M. Honan, C. D. Emmett, C. L. Pettey, H. Adari, R. A. Hammond, D. T. Beattie, et al. Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): 2106 - 2112. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dachet, O. Poirier, F. Cambien, J. Chapman, and M. Rouis New Functional Promoter Polymorphism, CETP/-629, in Cholesteryl Ester Transfer Protein (CETP) Gene Related to CETP Mass and High Density Lipoprotein Cholesterol Levels : Role of Sp1/Sp3 in Transcriptional Regulation Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 507 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. von Kodolitsch, R. E. Pyeritz, and P. K. Rogan Splice-Site Mutations in Atherosclerosis Candidate Genes : Relating Individual Information to Phenotype Circulation, August 17, 1999; 100(7): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Engfelt, K. R. Masuda, V. G. Paton, and S. K. Krisans Splice donor site mutations in the 3-hydroxy-3-methylglutaryl coenzyme A reductase gene cause a deficiency of the endoplasmic reticulum 3-hydroxy-3-methylglutaryl coenzyme A reductase protein in UT2 cells J. Lipid Res., November 1, 1998; 39(11): 2182 - 2191. [Abstract] [Full Text] |
||||
![]() |
C. Bruce, D. S. Sharp, and A. R. Tall Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia J. Lipid Res., May 1, 1998; 39(5): 1071 - 1078. [Abstract] [Full Text] |
||||
![]() |
E. M. Teh, P. J. Dolphin, W. C. Breckenridge, and M.-H. Tan Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America J. Lipid Res., February 1, 1998; 39(2): 442 - 456. [Abstract] [Full Text] |
||||
![]() |
A. Ritsch, H. Drexel, F. W. Amann, C. Pfeifhofer, and J. R. Patsch Deficiency of Cholesteryl Ester Transfer Protein : Description of the Molecular Defect and the Dissociation of Cholesteryl Ester and Triglyceride Transport in Plasma Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3433 - 3441. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |